Additional Information

Description

Enclomiphene 12.5 mg is a selective estrogen receptor modulator (SERM) primarily used in the treatment of secondary hypogonadism in men. This condition arises when the testes fail to produce adequate testosterone due to insufficient stimulation by gonadotropins from the pituitary gland. Enclomiphene acts by blocking estrogen receptors in the hypothalamus, enhancing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn stimulate endogenous testosterone production.

The drug is typically prescribed for male infertility and testosterone deficiency, especially in patients seeking to maintain fertility while increasing testosterone levels. It is administered orally at a dosage of 12.5 mg once daily. Consistent monitoring of serum testosterone levels is recommended to ensure therapeutic efficacy and prevent supraphysiologic levels. 

Enclomiphene may cause adverse effects such as hot flashes and visual disturbances. These side effects are typically dose-dependent and may vary among individuals. It is essential to inform healthcare providers of any visual changes or other unusual symptoms during treatment.